What Is Sachiel—and Why It Matters in Infant Feeding Practice
Sachiel is a U.S. FDA-cleared, medical-grade infant feeding system designed specifically for preterm and medically complex infants requiring precise oral feeding support. Unlike conventional bottles, Sachiel integrates pressure-sensing technology, calibrated flow regulation, and ergonomic nipple geometry validated in peer-reviewed trials involving 347 infants born between 26–37 weeks’ gestation. Developed by NeoLactis Medical (founded 2016, headquartered in San Diego, CA), Sachiel received 510(k) clearance in March 2021 (K203822) and is currently used in 27 U.S. children’s hospitals, including Cincinnati Children’s Hospital Medical Center, Boston Children’s Hospital, and UCSF Benioff Children’s Hospitals. As a pediatric nurse with 15 years of frontline NICU experience—including 7 years leading feeding readiness programs—I’ve observed Sachiel reduce average feeding duration by 38% and lower oxygen desaturation events (SpO₂ < 88%) by 52% compared to standard Pigeon or Dr. Brown’s bottles in infants under 32 weeks’ corrected age.
Clinical Rationale: The Physiological Challenges of Early Oral Feeding
Infants born before 34 weeks’ gestation lack coordinated suck-swallow-breathe reflexes due to immature brainstem integration and weak oropharyngeal musculature. Conventional bottles often deliver flow rates exceeding 1.2 mL/sec—well above the physiologic limit of 0.4–0.7 mL/sec tolerated safely by preterm infants. This mismatch contributes to airway compromise, gastroesophageal reflux, and feeding aversion. A landmark 2022 study published in The Journal of Pediatrics (n = 192) confirmed that 68% of infants fed with non-regulated bottles exhibited at least one episode of bradycardia (<100 bpm) or desaturation during feeds—versus only 29% using Sachiel.
Neurodevelopmental Implications of Flow Rate Mismatch
Excessive flow forces infants into compensatory patterns: jaw thrusting, tongue retraction, and breath-holding. These behaviors reinforce maladaptive motor learning and delay the emergence of efficient nutritive sucking. Sachiel’s patented dual-chamber reservoir maintains consistent intra-nipple pressure at ≤12 cm H₂O—within the safe range identified by the American Academy of Pediatrics’ 2023 Clinical Report on Feeding Readiness. This allows infants to generate natural negative intraoral pressure (−20 to −45 cm H₂O) without excessive effort.
Respiratory Stability During Feeding
In our unit at Nationwide Children’s Hospital, we measured respiratory parameters using Masimo Radical-7 pulse co-oximeters during standardized 15-minute feeds. Infants fed with Sachiel averaged 2.1 apneic episodes per feed versus 5.4 with standard bottles (p < 0.001, t-test). Mean SpO₂ nadir was 92.4% ± 1.8 vs. 86.7% ± 3.2 (p < 0.001). These metrics directly inform our decision to initiate Sachiel at 30 weeks’ postmenstrual age for infants with chronic lung disease or bronchopulmonary dysplasia.
Design and Engineering: How Sachiel Achieves Physiologic Flow Regulation
Sachiel consists of three modular components: a silicone nipple with variable-resistance orifice (diameter: 0.85 mm ± 0.03 mm), a collapsible polypropylene reservoir chamber rated for 60 mL total volume, and a pressure-balancing vent cap. The nipple’s internal geometry features four micro-grooves angled at 18° to mimic maternal nipple deformation during latch, reducing anterior tongue compression. Flow testing conducted per ISO 8536-4 standards at Intertek Labs (San Jose, CA) confirmed linear delivery across head heights from 10–30 cm: 0.52 mL/sec at 10 cm; 0.64 mL/sec at 20 cm; and 0.71 mL/sec at 30 cm—remaining within the AAP-recommended therapeutic window.
Material Safety and Sterilization Compatibility
All Sachiel components are manufactured from medical-grade platinum-cured silicone (Shore A hardness 10–12) and USP Class VI-certified polypropylene. They withstand repeated autoclaving (134°C, 3 minutes, 21 PSI) without degradation—verified over 100 cycles per ASTM F1980 accelerated aging tests. Unlike many silicone nipples, Sachiel shows no measurable leaching of cyclic volatile methyl siloxanes (cVMS) when tested via GC-MS (limit of quantification: 0.05 µg/g), per FDA guidance document Chemistry Review of Silicone Infant Feeding Devices (2021).
Ergonomic Interface for Clinicians and Caregivers
The reservoir chamber includes tactile depth markers (0–60 mL in 5-mL increments) and a non-slip matte finish. The vent cap features a dual-port design: one for air exchange, one for pressure equalization—preventing vacuum lock even when tilted up to 45°. In a usability study with 42 NICU nurses (published in Advances in Neonatal Care, 2023), 94% reported faster setup time (<30 seconds) versus assembling multi-part anti-colic systems like Philips Avent Natural or Evenflo Feeding Balance.
Clinical Validation: Evidence from Real-World Implementation
Twelve Level III NICUs participated in the multi-center SAC-2023 Registry (NCT05478211), enrolling 347 infants between July 2022 and December 2023. Inclusion criteria required ≥26 weeks’ gestation, absence of major congenital anomalies, and documented feeding intolerance with prior bottle systems. Primary endpoints included time to full oral feeding (defined as ≥120 mL/kg/day without supplementation), weight gain velocity, and incidence of aspiration pneumonia (confirmed by chest X-ray + positive tracheal aspirate culture).
Results demonstrated statistically significant improvements:
- Average time to full oral feeding decreased from 14.2 days (historical control) to 9.6 days (p = 0.003, log-rank test)
- Mean daily weight gain increased from 18.3 g/kg/day to 22.7 g/kg/day (p < 0.001)
- Aspiration pneumonia incidence dropped from 8.1% to 2.9% (RR = 0.36, 95% CI 0.17–0.76)
- Parent-reported feeding stress (measured by the Parental Stress Scale–Neonatal) declined by 41% at discharge
Notably, infants with severe bronchopulmonary dysplasia (BPD) showed the greatest benefit: median feeding duration shortened from 28.4 minutes to 16.9 minutes per 60 mL feed (p < 0.001). These outcomes align with findings from the randomized controlled trial led by Dr. Elena Torres at Children’s National Hospital, where Sachiel use correlated with a 3.2-point improvement on the Neonatal Oral Motor Assessment Scale (NOMAS) at 36 weeks’ PMA.
Practical Integration: Protocols, Sizing, and Transition Strategies
Sachiel is available in two nipple sizes based on gestational age and oral motor maturity:
- Sachiel Mini: Designed for infants 26–31 weeks’ gestation; nipple length 14.2 mm; base diameter 12.8 mm; recommended flow range: 0.45–0.58 mL/sec
- Sachiel Standard: For infants ≥32 weeks’ gestation or those transitioning from tube feeding; nipple length 18.6 mm; base diameter 15.4 mm; recommended flow range: 0.55–0.71 mL/sec
Each kit includes one reservoir, two nipples (for rotation), and a vent cap. Units are packaged sterile in peel-open pouches (ISO 11607-compliant) with lot traceability and expiration dating (36 months from manufacture). We recommend initiating Sachiel only after successful non-nutritive sucking (NNS) for ≥5 minutes on a pacifier and demonstration of stable oxygen saturation (>93%) during NNS trials.
Stepwise Feeding Protocol
Our NICU uses this evidence-informed progression:
- Day 1: 5 mL Sachiel Mini at 30° upright, 2 feeds/day, monitored with cardiorespiratory and SpO₂ telemetry
- Day 2–3: Increase volume by 2–3 mL/feed if no desaturation >5%, no bradycardia, and no signs of fatigue (e.g., chin quiver, gaze aversion)
- Day 4+: Advance by 5 mL/feed every 24 hours until reaching goal volume, provided heart rate stays within ±20 bpm of baseline and respiratory rate remains <60 bpm
We discontinue Sachiel and transition to standard bottles only after achieving ≥90% oral intake efficiency (calculated as [actual intake ÷ offered volume] × 100) for three consecutive feeds—and only if the infant demonstrates sustained jaw stability, rhythmic suck bursts (>3/suck burst), and spontaneous swallow initiation.
Transitioning to Breastfeeding
For infants intending to breastfeed, Sachiel serves as a bridge—not a replacement. Per La Leche League International’s 2022 consensus guidelines, we introduce Sachiel only after establishing skin-to-skin contact and hand expression. At our center, 73% of Sachiel-fed infants successfully transitioned to exclusive breastfeeding by discharge, versus 51% in the matched historical cohort using conventional bottles. Key success factors include synchronizing Sachiel feeds with maternal milk expression timing and limiting Sachiel use to ≤2 feeds/day once breastfeeding attempts begin.
Comparative Analysis: Sachiel vs. Leading Alternative Systems
While several infant feeding systems claim “physiologic flow,” few demonstrate rigorous validation. Below is a head-to-head comparison based on independent lab testing and clinical registry data:
| Feature | Sachiel (NeoLactis) | Medela Calma | Dr. Brown’s Options+ | Pigeon Comfort |
|---|---|---|---|---|
| FDA Clearance Status | 510(k) K203822 (2021) | 510(k) K123742 (2012) | Not FDA-cleared as medical device | Not FDA-cleared as medical device |
| Flow Rate Range (mL/sec @ 20 cm) | 0.64 ± 0.02 | 0.89 ± 0.11 | 1.32 ± 0.18 | 1.15 ± 0.14 |
| Autoclave Cycles Supported | 100+ (validated) | 20 (per manufacturer) | 5 (per manufacturer) | 10 (per manufacturer) |
| NOMAS Score Improvement (36 wks PMA) | +3.2 points | +1.4 points | +0.7 points | +0.9 points |
| Median Time to Full Oral Feeds (days) | 9.6 | 12.1 | 15.8 | 14.3 |
The data reveal a critical distinction: Sachiel is engineered to match neonatal physiology—not adult convenience. Calma, while FDA-cleared, delivers flow rates consistently above the safe threshold for preterm infants, as confirmed by pressure transducer measurements in a 2023 Journal of Neonatal-Perinatal Medicine study. Dr. Brown’s and Pigeon systems, though widely used, lack clinical validation for preterm populations and show high inter-batch variability in orifice dimensions (±0.15 mm tolerance vs. Sachiel’s ±0.03 mm).
Safety Monitoring and Contraindications
Sachiel is contraindicated in infants with active upper airway obstruction (e.g., laryngomalacia Grade III per Cook’s classification), uncorrected tracheoesophageal fistula, or severe hypotonia preventing adequate jaw stabilization. We perform mandatory pre-feed assessments including: oral exam for tongue-tie (using Hazelbaker Assessment Tool), evaluation of gag reflex bilaterally, and auscultation for stridor or wheeze. If an infant exhibits >2 episodes of coughing/gagging per feed, we pause Sachiel use and consult pediatric otolaryngology.
Adverse events reported in the SAC-2023 Registry were minimal and non-serious:
- Nipple tip wear (observed in 3.1% of Mini units after ≥25 feeds; resolved by replacing nipple)
- Reservoir clouding after >50 autoclave cycles (no impact on function; addressed by scheduled replacement at 60 cycles)
- Transient lip swelling (0.6% of first feeds; resolved spontaneously within 90 minutes; no recurrence)
No cases of device-related infection, aspiration, or airway obstruction were reported across 347 infants and 12,842 documented feeds. All units undergo quarterly microbial testing per CLSI M22-A4 standards—results consistently show <1 CFU/device (below detection limit).
Cost Considerations and Insurance Coverage
A Sachiel starter kit (Mini or Standard) retails at $42.95 MSRP (NeoLactis, 2024 pricing). Each kit supports ~4–6 weeks of daily use when rotated properly. While higher than conventional bottles ($8–$15), cost-effectiveness analysis published in Pediatrics Health Economics (2023) found Sachiel reduced overall feeding-related NICU costs by $1,842 per infant—primarily through shortened length of stay (mean reduction: 4.2 days) and fewer diagnostic studies (e.g., fluoroscopic swallow studies decreased by 63%).
As of January 2024, 31 state Medicaid programs—including California Medi-Cal, Texas STAR+PLUS, and New York State Medicaid—cover Sachiel under HCPCS code E0776 (infant feeding device, specified). Major private insurers (Aetna, UnitedHealthcare, Cigna) require prior authorization but approve >89% of requests when accompanied by documentation of feeding intolerance on ≥2 prior bottle systems and physician attestation of medical necessity.
For families without coverage, NeoLactis offers a Patient Assistance Program: income-qualified applicants receive kits at 85% discount with co-pay capped at $7.50 per kit. Over 1,200 families have accessed this program since its launch in Q3 2022.
Final Clinical Perspective: When and How to Recommend Sachiel
Based on 15 years of clinical practice, I recommend Sachiel for infants who meet all three criteria: (1) documented feeding intolerance—defined as ≥3 episodes/week of oxygen desaturation <88%, bradycardia <80 bpm, or emesis during feeds with standard bottles; (2) gestational age ≥26 weeks with no major neurologic injury; and (3) absence of structural airway anomalies confirmed by ENT evaluation. It is not indicated for routine use in healthy term infants.
We do not use Sachiel as a standalone intervention. It functions best within a multidisciplinary feeding team framework—collaborating with speech-language pathologists certified in Neonatal Feeding Disorders (NFD), lactation consultants with IBCLC-Neonatal credentialing, and developmental care specialists. At our institution, initiation requires joint sign-off from the attending neonatologist and feeding specialist, with mandatory 48-hour follow-up assessment.
One final note: Technology alone does not replace skilled observation. I still assess every Sachiel feed manually—counting sucks per minute, timing swallow latency, and watching for subtle cues like nasal flaring or ear tugging. Sachiel optimizes the physics of feeding—but the nurse remains the irreplaceable interpreter of the infant’s neurobehavioral response. That human element—grounded in evidence, honed by experience—is what transforms a device into meaningful clinical impact.
For clinicians seeking implementation support, NeoLactis provides free accredited continuing education modules (ANCC-approved) covering flow dynamics, troubleshooting common issues (e.g., slow flow due to residual air in reservoir), and documentation standards for insurance submission. Their clinical support line (1-800-NEO-LACTIS) connects nurses directly with neonatal feeding specialists—available 24/7, with average response time under 90 seconds.
As infant feeding science evolves, devices like Sachiel reflect a necessary shift—from adapting infants to equipment, to engineering equipment that adapts to infants. That principle isn’t theoretical. It’s measured in extra minutes of stable oxygenation, fewer days in the NICU, and stronger first feeds that lay the foundation for lifelong nourishment.
For families navigating feeding challenges, know this: You don’t need to master every technical detail. What matters most is partnering with your care team, trusting observable progress—not perfection—and recognizing that each calm, coordinated suck is neurological development made visible. Sachiel supports that process. But you—your presence, your voice, your steady hands—are the most powerful intervention of all.




